Ondansetron in Treatment Resistant Obsessive Compulsive Disorder (OCD)

NCT00796497 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Obsessive Compulsive Disorder

Interventions

DRUG: ondansetron

Sponsor

Institute of Neuroscience, Florence, Italy